Bolder Biotechnology Inc

Bolder Biotechnology Inc., based in Boulder, Colorado, specializes in advanced protein engineering to develop innovative, cost-effective protein therapeutics aimed at improving patient outcomes. Their diversified product pipeline includes treatments for a range of health conditions, including hematological and endocrine disorders, cancer, and infectious diseases.

The company employs proprietary technologies such as Site-Specific PEGylation and ImmunoFusion Protein technology to enhance the efficacy and longevity of their therapeutic products. Additionally, Bolder Biotechnology is actively engaged in bio-defense initiatives supported by the U.S. government, focusing on developing treatments for acute radiation syndrome and other critical health challenges.

Generated from the website